Chemical activators of Serpinb3d are diverse and work through a variety of intracellular pathways to influence its activity. Sodium orthovanadate acts by inhibiting protein tyrosine phosphatases, leading to an increase in phosphorylation levels within the tyrosine phosphorylation pathway, which can enhance the activity of Serpinb3d. Calpeptin operates by preventing calpain-mediated proteolytic cleavage, potentially resulting in the accumulation of proteins that interact with or regulate Serpinb3d, thereby increasing its activity. Additionally, MG-132, by inhibiting the proteasome, staves off protein degradation, leading to a stabilized cellular environment that can favor Serpinb3d activation. Forskolin raises intracellular cAMP levels, activating protein kinase A (PKA), which may phosphorylate Serpinb3d or its associated proteins, leading to its activation. Phorbol 12-myristate 13-acetate (PMA) stimulates protein kinase C (PKC), which can phosphorylate Serpinb3d directly or indirectly, modulating its activity.
Further, Anisomycin disrupts protein synthesis and activates stress-activated protein kinases, which could phosphorylate regulatory proteins related to Serpinb3d activity. Okadaic acid, by inhibiting phosphatases like PP1 and PP2A, fosters a phosphorylation state that can enhance the activity of Serpinb3d. LY294002 interferes with the PI3K pathway, resulting in alterations that may activate Serpinb3d. SB203580 and U0126, inhibitors of p38 MAP kinase and MEK1/2 respectively, can lead to the activation of alternative signaling pathways that involve Serpinb3d. SP600125, by inhibiting JNK, can alter cellular processes and consequentially activate Serpinb3d. Lastly, KN-93's inhibition of CaMKII can influence calcium signaling, which may result in the activation of Serpinb3d as the cell responds to changes in calcium-dependent regulations. All these chemical activators work through different mechanisms to modulate the activity of Serpinb3d, influencing its role within the cell.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
Sodium orthovanadate is known to inhibit protein tyrosine phosphatases. Inhibition of these phosphatases can lead to an increase in phosphorylation levels of proteins within the tyrosine phosphorylation pathway, which includes Serpinb3d. This increased phosphorylation can enhance Serpinb3d activity as it might be involved in such signaling cascades. | ||||||
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $121.00 $456.00 | 28 | |
Calpeptin is a calpain inhibitor. By inhibiting calpain, it prevents the proteolytic cleavage of proteins, which can result in the accumulation of proteins that are substrates for this protease. This accumulation could lead to an increase in Serpinb3d activity, assuming Serpinb3d is a substrate or is regulated by proteins that are substrates. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 is a proteasome inhibitor, which prevents the degradation of proteins by the ubiquitin-proteasome pathway. Proteins that are stabilized due to the inhibition of their degradation can activate Serpinb3d by stabilizing the cellular environment, including proteins that interact with or regulate Serpinb3d activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which phosphorylates serine and threonine residues on various proteins. The activation of PKC and subsequent phosphorylation events can lead to the activation of Serpinb3d through direct phosphorylation or by phosphorylating proteins that interact with Serpinb3d. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a protein synthesis inhibitor that also activates stress-activated protein kinases, such as JNK and p38. Activation of these kinases can lead to the phosphorylation and activation of substrates and regulatory proteins, potentially including Serpinb3d. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels within the cell. This can activate Serpinb3d by preventing its dephosphorylation or by altering phosphorylation states of proteins in pathways where Serpinb3d is active. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of the phosphoinositide 3-kinases (PI3K). Inhibition of PI3K can lead to alterations in downstream signaling pathways, such as AKT, which may activate Serpinb3d through changes in the phosphorylation status of proteins in these pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAP kinase. Inhibition of p38 can lead to changes in the cellular stress response and may activate Serpinb3d through the alteration of regulatory networks that include stress response proteins. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, leading to inhibition of the ERK pathway. This inhibition can cause a compensatory activation of alternative pathways that may include Serpinb3d, thus activating it indirectly through pathway crosstalk. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). Inhibition of JNK signaling can lead to changes in cellular processes, such as apoptosis or inflammation, and may result in the activation of Serpinb3d as part of the cellular response. | ||||||